Ranking tables
Healthcare: Pharmaceutical/Medical Products Regulatory | USA
District of Columbia
Rankings overview for Departments
Band 1
Band 2
Band 3
Goodwin 3 Years Ranked
Morgan, Lewis & Bockius LLP 18 Years Ranked- Hyman Phelps & McNamara
Band 4
Akin 5 Years Ranked
Alston & Bird LLP 9 Years Ranked
ArentFox Schiff LLP 4 Years Ranked
Baker McKenzie 2 Years Ranked
BakerHostetler LLP 5 Years Ranked
McDermott Will & Emery LLP 4 Years Ranked
Polsinelli PC 2 Years Ranked
Reed Smith LLP 4 Years Ranked
Skadden, Arps, Slate, Meagher & Flom LLP & Affiliates 10 Years Ranked
Senior Statespeople
- Jonathan S Kahan Hogan Lovells US LLP18 Years Ranked
Peter O Safir Covington & Burling LLP18 Years Ranked- Jeffrey N GibbsHyman Phelps & McNamara
Band 1
Daniel Kracov Arnold & Porter16 Years Ranked- David Fox Hogan Lovells US LLP17 Years Ranked
Jeffrey L Handwerker Arnold & Porter12 Years Ranked
Jennifer Bragg Skadden, Arps, Slate, Meagher & Flom LLP & Affiliates12 Years Ranked- John Manthei Latham & Watkins LLP15 Years Ranked
Michael S Labson Covington & Burling LLP16 Years Ranked
Band 2
Cathy Burgess Alston & Bird LLP7 Years Ranked
Denise Esposito Covington & Burling LLP7 Years Ranked
Gregory Levine Ropes & Gray LLP14 Years Ranked
Kathleen M Sanzo Morgan, Lewis & Bockius LLP15 Years Ranked
Kellie Combs Ropes & Gray LLP7 Years Ranked
Nathan Brown Akin6 Years Ranked- Philip Katz Hogan Lovells US LLP9 Years Ranked
Raymond A Bonner Sidley Austin LLP14 Years Ranked
Rebecca K. Wood Sidley Austin LLP3 Years Ranked
Vernessa Pollard DLA Piper LLP (US)11 Years Ranked
William B Schultz Zuckerman Spaeder LLP4 Years Ranked
William McConagha Skadden, Arps, Slate, Meagher & Flom LLP & Affiliates3 Years Ranked- Scott M. LassmanLassman Law + Policy
Band 3
Brian Waldman ArentFox Schiff LLP6 Years Ranked
Celeste Letourneau Troutman Pepper3 Years Ranked- Elizabeth Richards Latham & Watkins LLP3 Years Ranked
- J Benneville Haas Latham & Watkins LLP4 Years Ranked
John D. Shakow King & Spalding LLP3 Years Ranked
Julie Tibbets Goodwin6 Years Ranked
Kevin Madagan Reed Smith LLP3 Years Ranked
Lee H Rosebush BakerHostetler LLP6 Years Ranked
Mark S Brown King & Spalding LLP5 Years Ranked- Meredith Manning Hogan Lovells US LLP13 Years Ranked
- Michael Heyl Hogan Lovells US LLP3 Years Ranked
Michael M. Gaba Polsinelli PC11 Years Ranked
Nikki Reeves King & Spalding LLP3 Years Ranked
Paul D. Rubin Debevoise & Plimpton LLP6 Years Ranked
Seth H Lundy King & Spalding LLP13 Years Ranked- Kurt KarstHyman Phelps & McNamara
Band 4
Areta Kupchyk Foley Hoag LLP2 Years Ranked- David Horowitz Hogan Lovells US LLP2 Years Ranked
- John J Smith Hogan Lovells US LLP4 Years Ranked
Krista Hessler Carver Covington & Burling LLP4 Years Ranked
Michele Buenafe Morgan, Lewis & Bockius LLP2 Years Ranked
Pamela Forrest Covington & Burling LLP2 Years Ranked
Paul Radensky McDermott Will & Emery LLP5 Years Ranked
Peter Lindsay Paul Hastings LLP1 Years Ranked- Sonia Nath Cooley LLP1 Years Ranked
Stacy Cline Amin Morrison Foerster2 Years Ranked- Edward John AlleraBuchanan Ingersoll & Rooney PC
- Josephine TorrenteHyman Phelps & McNamara
All Departments profiles
Band 1
1 Covington & Burling LLPHealthcare: Pharmaceutical/Medical Products Regulatory2023 | Band 1 | 19 Years RankedA powerhouse in the pharmaceutical and medical device industry with extensive experience advising on product development, manufacturing and pharmacovigilance. Retained by clients for its proficiency dealing with regulatory bodies including the FDA and Consumer Product Safety Commission.
1 Hogan Lovells US LLPHealthcare: Pharmaceutical/Medical Products Regulatory2023 | Band 1 | 18 Years RankedDistinguished team with deep expertise across the scope of the healthcare and life sciences industries. Handles complex issues including the regulation of new medical devices, biotechnology products and healthcare litigation. Strengths also include government price reporting, privacy and reimbursement issues. Expertise extends to advising on transactions such as clinical integrations, M&A and contracting. Noted for its focus on digital health concerns.
1 Sidley Austin LLPHealthcare: Pharmaceutical/Medical Products Regulatory2023 | Band 1 | 18 Years RankedMultitalented team that attracts an impressive breadth of work in the sector, representing both healthcare providers and manufacturers in relation to complex clinical matters, including research trial compliance. Also advises on an array of regulatory issues including pricing, reimbursement and coverage. Frequently retained on high-stakes government investigations, with experience across criminal and civil matters.
Band 2
2 Arnold & PorterHealthcare: Pharmaceutical/Medical Products Regulatory2023 | Band 2 | 19 Years RankedImpressive team with wide-ranging expertise in healthcare, pharmaceutical and medical device matters, including innovative technology and compliance issues. Integrated life sciences practice offers strong IT services to clients, alongside FDA and healthcare regulatory compliance counseling. Notable litigation capabilities include both civil and criminal defense work. Offers strength acting for organizational as well as individual clients in the healthcare space.
2 King & Spalding LLPHealthcare: Pharmaceutical/Medical Products Regulatory2023 | Band 2 | 18 Years RankedStrong regulatory capabilities and litigation strength, frequently advising on high-value Medicare reimbursement appeals for hospitals. Also acts on M&A and joint ventures involving providers, as well as health IT concerns. Also noted for its experience in the pharmaceutical and biotech space, advising on areas such as clinical trials, marketing and disputes. Offers skill in handling drug-pricing issues for pharmaceutical manufacturers.
2 Latham & Watkins LLPHealthcare: Pharmaceutical/Medical Products Regulatory2023 | Band 2 | 7 Years RankedAdvises a wide range of healthcare entities, including hospitals, laboratories and distributors, on complex investigations and transactions. Interdisciplinary approach offers clients varied expertise in areas such as qui tam litigation and capital markets investment. Also acts on administrative challenges and FDA regulatory issues. Clients also include companies in the pharmaceutical, medical device manufacturing and biotech industries.
2 Ropes & Gray LLPHealthcare: Pharmaceutical/Medical Products Regulatory2023 | Band 2 | 18 Years RankedRobust practice sought after for a range of matters spanning healthcare, medical device and pharmaceutical issues. Offers substantial experience in regulatory issues including compliance and investigations work, coupled with pharmaceutical expertise encompassing advertising and patent advice. Also noted for arguing cases in trial and appellate courts.
Band 3
3 GoodwinHealthcare: Pharmaceutical/Medical Products Regulatory2023 | Band 3 | 3 Years RankedCounsels a broad range of clients including pharmaceuticals and medical device manufacturers on complex FDA regulatory issues. Noted for its significant expertise in compliance related to new drug and device development and its strong cross-border capabilities. Also acts on transactions such as the sale of drug rights.3 Morgan, Lewis & Bockius LLPHealthcare: Pharmaceutical/Medical Products Regulatory2023 | Band 3 | 18 Years RankedDemonstrates extensive capabilities in health law compliance matters, including investigations and other regulatory challenges. Attracts a broad roster of clients, including healthcare service providers, pharmaceutical and biotech companies. Frequently acts on civil and criminal litigation, as well as representing private equity firms in high-value healthcare acquisitions. Offers notable expertise in advising on complex coverage and reimbursement issues. Also noted for its FDA regulatory capabilities.- Hyman Phelps & McNamaraHealthcare: Pharmaceutical/Medical Products Regulatory2023 | Band 3
Band 4
4 AkinHealthcare: Pharmaceutical/Medical Products Regulatory2023 | Band 4 | 5 Years RankedA strong force in the healthcare market that acts for multiple high-profile clients. Excels across the range of regulatory and litigation work, regularly representing clients in investigations and disputes with government bodies. Expertise includes Medicare reimbursement disputes and False Claims Act claims. Also possesses experience advising healthcare clients on due diligence and other aspects of transactional matters.4 Alston & Bird LLPHealthcare: Pharmaceutical/Medical Products Regulatory2023 | Band 4 | 9 Years RankedOffers a wealth of expertise in FDA enforcement and compliance matters, with broad cross-border capabilities. Noted for advising drug manufacturers on a range of issues including warning letters, HIPAA and fraud and abuse matters. Also counsels on compliance issues in new product developments.4 ArentFox Schiff LLPHealthcare: Pharmaceutical/Medical Products Regulatory2023 | Band 4 | 4 Years RankedStrong team noted for its handling of wide-ranging matters, including regulatory compliance, external investigations and litigation. Particularly adept at fraud and abuse matters, with significant expertise in high-stakes False Claims Act matters. Also offers experience in drug pricing and FDA regulatory issues for pharmaceutical and medical device companies.4 Baker McKenzieHealthcare: Pharmaceutical/Medical Products Regulatory2023 | Band 4 | 2 Years RankedThe Baker McKenzie team offers broad expertise on a range of regulatory issues, including, but not limited to, FDA regulatory compliance and the commercialization of products. The team has significant experience of handling transactions. They are also called upon to provide counsel on the development of internal compliance protocols. The group routinely advises pharmaceutical and medical device companies.4 BakerHostetler LLPHealthcare: Pharmaceutical/Medical Products Regulatory2023 | Band 4 | 5 Years RankedNotable experience in high-profile FDA mandates. Regularly advises pharmaceutical clients and providers as well as private equity funds on regulatory issues such as those connected to new drug applications and advertising matters. Expertise in negotiating pharmacy benefit management contracts. Also offers strong skills in a broad range of transactions including sale of assets and joint ventures.4 McDermott Will & Emery LLPHealthcare: Pharmaceutical/Medical Products Regulatory2023 | Band 4 | 4 Years RankedPremier group with diverse subject matter expertise, handling complex transactional and regulatory matters for an enviable client list. Represents a range of clients, notably healthcare providers and private equity firms, across the full spectrum of healthcare work, including lobbying and policy matters. Regularly advises on civil litigation and high-stakes enforcement proceedings. Expertise extends to FDA regulatory compliance.4 Polsinelli PCHealthcare: Pharmaceutical/Medical Products Regulatory2023 | Band 4 | 2 Years RankedPolsinelli has a significant healthcare practice. The practitioners are routinely called upon to assist with FDA regulatory issues. The team is noted for their representation of medical device manufacturers in a range of issues. They are adept at handling matters related to HIPAA compliance, data privacy and security, as well as Medicare coverage and payment issues.4 Reed Smith LLPHealthcare: Pharmaceutical/Medical Products Regulatory2023 | Band 4 | 4 Years RankedExcellent healthcare team that maintains a strong profile for regulatory work, including reimbursement and transactional due diligence. Regularly advises care providers, investors and new technology manufacturers, among others. Experience includes advising on external investigations conducted by government bodies such as the DOJ. Also counsels pharmaceutical and medical device manufacturers on FDA regulation and fraud and abuse matters.4 Skadden, Arps, Slate, Meagher & Flom LLP & AffiliatesHealthcare: Pharmaceutical/Medical Products Regulatory2023 | Band 4 | 10 Years RankedWell-regarded team offering knowledge across a broad range of industry concerns. Provides high-level advice on regulatory compliance and enforcement proceedings. Noted for strength in both civil and criminal litigation, and also draws on significant transactional capabilities. Acts for a range of life sciences companies alongside providers, fielding increasing strength in FDA regulatory issues. Also noted for its handling of issues arising from the opioid sector.